Amryth Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Amryth Pharma. Real-time updates on events, politics, business and more.

Epidermolysis Bullosa Market to Surge at a CAGR of ~8% During the Study Period (2019-2032), Predicts DelveInsight

August 10, 2023

/PRNewswire/ -- DelveInsights Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices,...

United States United Kingdom Chiesi Farmaceutici Dabocemagene Autoficel Filsuvez Oleogel Holostem Terapie Avanzate

Source: prnewswire.com

Dystrophic Epidermolysis Bullosa Market to Surge at a CAGR of 9.1% by 2032

October 5, 2022

/PRNewswire/ -- DelveInsights Dystrophic Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices,...

United States United Kingdom Shruti Thakur Beremagene Geperpavec Amryth Pharma Inmed Pharmaceuticals

Source: prnewswire.com

DelveInsight Business Research, LLP: Dystrophic Epidermolysis Bullosa Market to Surge at a CAGR of 9.1% by 2032

October 5, 2022

DelveInsight's expert analysts estimate that the dystrophic epidermolysis bullosa market is expected to show positive growth, mainly attributed to increased dystrophic epidermolysis bullosa prevalence

United States United Kingdom Shruti Thakur Kostenloser Wertpapierhandel Beremagene Geperpavec Amryth Pharma

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Amryth Pharma News Today

Epidermolysis Bullosa Market to Surge at a CAGR of ~8% During the Study Period (2019-2032), Predicts DelveInsight

Dystrophic Epidermolysis Bullosa Market to Surge at a CAGR of 9.1% by 2032

DelveInsight Business Research, LLP: Dystrophic Epidermolysis Bullosa Market to Surge at a CAGR of 9.1% by 2032

Explore More Categories